Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: Harold Engstrom who wrote (136)	11/24/1998 9:22:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1475

Harold: There is, to my knowledge, no link. And that was pretty much the summary of the CD40L part. If I have time later today, I'll comment on the remainder of the article. BTRN languishing? It's orphaned, first, no expected news until the phase I results for allomune, phase II for 507 or partnering of allo, none of which is thought to be imminent, second, and tax selling, third. There may be a fourth...... perhaps some don't expect positive results, but I'm not aware of any reason for a bias. Rick